Trefoil Therapeutics Funding: $50M Raised, Series B
Trefoil Therapeutics is based in San Diego, California. It has raised $50M in total funding. Latest round: Series B.
Trefoil Therapeutics funding overview
Trefoil Therapeutics is based in San Diego, California. Trefoil Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners and 1 others. 7 distinct backers are named across the disclosed rounds.
Trefoil Therapeutics at a glance
Total raised
$50M
Latest round
Series B
Headquarters
San Diego, California
Notable investors
Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners, InFocus Capital Partners
Frequently asked about Trefoil Therapeutics funding
How much has Trefoil Therapeutics raised?
Trefoil Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Trefoil Therapeutics?
Bios Partners, Access Biotechnology, Aju IB Investment, Correlation Ventures, ExSight Ventures, Hatteras Venture Partners are named among the investors backing Trefoil Therapeutics.
What was the latest Trefoil Therapeutics funding round?
The most recent disclosed round is a Series B.
Where is Trefoil Therapeutics based?
Trefoil Therapeutics is based in San Diego, California.
Trefoil Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
